Radionuclides in endocrine imaging.
Radiopharmaceuticals used in endocrine imaging encompass both standard and recently developed techniques used to diagnose diseases of the endocrine system. The initial part of this article deals with the characteristics of a suitable radionuclide/radiopharmaceutical required for successful scintigraphic endocrine imaging. The remainder of the article includes clinical applications and practical uses of developed scintigraphic agents in diagnosing disorders of the various endocrine glands. Finally, there is reference to the new and exciting neuropeptide imaging agent Octreoscan 111.